| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|
| NANOG | 20857 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.5461 | 34168259
|
| SOX2 | 11195 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.5695 | 34168259
|
| HNRNPAB | 5034 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.36 | 0.0032 | 34168259
|
| LDHA | 6535 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.36 | 0.0053 | 34168259
|
| VDAC2 | 12672 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.36 | 0.0011 | 34168259
|
| HDHA | NA | HTM/LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0011 | 34168259
|
| HNRNPAB | 5034 | HTM/LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics and Western Blotting | Down | 0.36 | 0.0032 | 34168259
|
| LDHA | 6535 | HTM/LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics and Western Blotting | Down | 0.36 | 0.0053 | 34168259
|
| VDAC2 | 12672 | HTM/LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0011 | 34168259
|
| CCNB1 | 1579 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by qPCR | NA | 0.2 | 0.0053 | 34168259
|
| FZD2 | 4040 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by qPCR | NA | 0.2 | 0.0021 | 34168259
|
| POU5F1 | 9221 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by qPCR | NA | 0.2 | 0.6448 | 34168259
|
| ACO2 | 118 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| AGR2 | 328 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 34168259
|
| AHNAK | 347 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| ALB | 399 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| ALDH2 | 404 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| ANPEP | 500 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0117 | 34168259
|
| ANXA11 | 535 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| ANXA13 | 536 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| ANXA2 | 537 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| ANXA3 | 541 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0085 | 34168259
|
| ANXA7 | 545 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| APEX1 | 587 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| API5 | 594 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| APMAP | 13238 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| ARF3 | 654 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| ARF4 | 655 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| ARHGEF19 | 26604 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| ARL6IP5 | 16937 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| ARPC2 | 705 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| ARPC5L | 23366 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| ASPH | 757 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| ATIC | 794 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| ATP1A1 | 799 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| ATP5ME | 846 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| ATP5MF | 848 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| ATP5PB | 840 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| BANF1 | 17397 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| BDH1 | 1027 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| BZW2 | 18808 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| C1QBP | 1243 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| C2orf72 | 27418 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| CALB2 | 1435 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 34168259
|
| CAND1 | 30688 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| CAPZB | 1491 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| CCAR2 | 23360 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| CCT2 | 1615 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| CCT4 | 1617 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| CDC42 | 1736 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| COX7A2 | 2288 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| CPSF6 | 13871 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| CPVL | 14399 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| CSE1L | 2431 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| CSTB | 2482 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| CTNNBL1 | 15879 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| CTNND1 | 2515 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| CTSD | 2529 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
| CUTA | 21101 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| CYB5R3 | 2873 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| CYC1 | 2579 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| CYCS | 19986 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| CYSTM1 | 30239 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| DDT | 2732 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| DDX18 | 2741 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| DDX21 | 2744 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| DERL1 | 28454 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| DHCR24 | 2859 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 34168259
|
| DHRS9 | 16888 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 34168259
|
| DHX9 | 2750 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
| DPY30 | 24590 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| DPYSL2 | 3014 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| DSP | 3052 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| ECH1 | 3149 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| EIF2AK2 | 9437 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| EIF4A1 | 3282 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| EPHX1 | 3401 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| ERGIC1 | 29205 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| FARSB | 17800 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| FBP1 | 3606 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| FIS1 | 21689 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| FKBP1A | 3711 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| FSCN1 | 11148 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 34168259
|
| FUS | 4010 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| G3BP1 | 30292 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| GART | 4163 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 34168259
|
| GFPT1 | 4241 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| GLS | 4331 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| GLUD1 | 4335 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| GNA13 | 4381 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| GNAI1 | 4384 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| GOLT1B | 20175 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| GOT2 | 4433 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| GPD2 | 4456 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| GPI | 4458 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| GSTP1 | 4638 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
| GTF2I | 4659 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| H1-0 | 4714 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| H1-2 | 4716 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
| H1-3 | 4717 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| H1-5 | 4719 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| H2AC18 | 4736 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| H2AC21 | 20508 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| H2AC6 | 4733 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| H2BC12 | 13954 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| H2BC13 | 4748 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| H2BC21 | 4760 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| H3-4 | 4778 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| HADHA | 4801 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| HADHB | 4803 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| HBE1 | 4830 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| HIBCH | 4908 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| HK1 | 4922 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| HMGB1 | 4983 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| HNRNPDL | 5037 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| HNRNPK | 5044 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| HNRNPU | 5048 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| HP1BP3 | 24973 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| HPCAL1 | 5145 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| HSD17B12 | 18646 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| HSPA5 | 5238 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0117 | 34168259
|
| HSPA6 | 5239 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 34168259
|
| HSPA9 | 5244 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| IGF2BP2 | 28867 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| IGF2BP3 | 28868 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| IL18 | 5986 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| ILF2 | 6037 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| ITGB4 | 6158 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0074 | 34168259
|
| KARS1 | 6215 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| KPNA4 | 6397 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| KRT18 | 6430 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0074 | 34168259
|
| KRT79 | 28930 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| KRT9 | 6447 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| LAMB3 | 6490 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0064 | 34168259
|
| LGALS3BP | 6564 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| LRRC59 | 28817 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| MDH1 | 6970 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
| ME3 | 6985 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| MGST3 | 7064 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| MOGS | 24862 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| MRPL28 | 14484 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| MSN | 7373 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| MVP | 7531 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| NAXE | 18453 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| NCEH1 | 29260 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| NIPSNAP1 | 7827 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| NOLC1 | 15608 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| NOP56 | 15911 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| NPC1 | 7897 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| NQO1 | 2874 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| OCIAD2 | 28685 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| PAFAH1B2 | 8575 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| PARK7 | 16369 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| PCK2 | 8725 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| PGAM1 | 8888 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| PGD | 8891 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 34168259
|
| PGRMC2 | 16089 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| PLS1 | 9090 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| PPP1CA | 9281 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| PRKAG1 | 9385 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| PSAP | 9498 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| PSMA3 | 9532 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| PSMA5 | 9534 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| PSMC5 | 9552 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| PSME1 | 9568 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| PSME2 | 9569 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| RAB1A | 9758 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| RALY | 15921 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| RALYL | 27036 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| RAP1A | 9855 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| RBM39 | 15923 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| RPL11 | 10301 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| RPL13A | 10304 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
| RPL14 | 10305 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| RPL17 | 10307 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| RPL24 | 10325 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| RPL4 | 10353 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| RPL6 | 10362 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| RPL7 | 10363 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| RPL7A | 10364 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| RPL9 | 10369 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| RPLP1 | 10372 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| RPN2 | 10382 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| RPS10 | 10383 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| RPS16 | 10396 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| RPS2 | 10404 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| RPS29 | 10419 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| RPS3 | 10420 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| RPS3A | 10421 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| RPS7 | 10440 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| RSL1D1 | 24534 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| RTN4 | 14085 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| S100A10 | 10487 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| S100A16 | 20441 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| SCARB2 | 1665 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| SDHA | 10680 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 34168259
|
| SEPTIN6 | 15848 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| SEPTIN7 | 1717 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| SET | 10760 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| SF3A1 | 10765 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| SFPQ | 10774 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| SFXN1 | 16085 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| SHMT2 | 10852 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| SLC25A1 | 10979 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| SLC25A10 | 10980 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| SLC25A3 | 10989 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| SLC25A6 | 10992 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| SLC2A1 | 11005 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| SLC3A2 | 11026 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0085 | 34168259
|
| SOD2 | 11180 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0064 | 34168259
|
| SRFBP1 | 26333 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| SRP14 | 11299 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| SRSF10 | 16713 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| STMN1 | 6510 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| STT3A | 6172 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| SUB1 | 19985 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| SUMF2 | 20415 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| SYNCRIP | 16918 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
| TALDO1 | 11559 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| TARDBP | 11571 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| TGM2 | 11778 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| TMPO | 11875 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| TOMM40 | 18001 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| TPI1 | 12009 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0042 | 34168259
|
| TPR | 12017 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| TSPAN8 | 11855 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| TSPO | 1158 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| TST | 12388 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| TUBA1C | 20768 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| TUBA4A | 12407 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| TXNDC17 | 28218 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0011 | 34168259
|
| U2AF2 | 23156 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| UGDH | 12525 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0053 | 34168259
|
| UGT1A10 | 12531 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0021 | 34168259
|
| VAT1 | 16919 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| VCL | 12665 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|
| VCP | 12666 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0042 | 34168259
|
| VKORC1L1 | 21492 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0011 | 34168259
|
| WARS1 | 12729 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| XPO1 | 12825 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| XRCC5 | 12833 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0032 | 34168259
|
| XRCC6 | 4055 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Down | 0.08 | 0.0053 | 34168259
|
| YWHAG | 12852 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0021 | 34168259
|
| YWHAQ | 12854 | HTM | Pancreatic Cancer | Ductal Adenocarcinoma | PC1J | NA | SFA followed by Proteomics | Up | 0.08 | 0.0032 | 34168259
|